The most recent genome-wide association study (GWAS) of MS susceptibility2, provides compelling evidence for the effects of 32 independent susceptibility variants in the major histocompatibility complex (MHC) and 200 autosomal non-MHC susceptibility variants. The gene discussed is HLA-C; the disease is myeloid sarcoma.